Royalty Pharma
Mr. Riggs co-founded Royalty Pharma in 1996 and assumed the role of chairman in 2003. Mr. Riggs is the founder & CEO of Syntax & Locus Analytics. Previously, Mr. Riggs was President of Biomatrix. Mr. Riggs serves or has served on several boards including Fibrogen, Cibus, Sugen, Intra-cellular Therapies, and Biomatrix. Mr. Riggs has a BA from Middlebury College and an MBA from Columbia University.
This person is not in the org chart
This person is not in any teams
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.